Canada markets close in 4 hours 32 minutes

Enliven Therapeutics, Inc. (ELVN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.30-0.51 (-2.14%)
As of 11:26AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
72,664
64,574
31,022
20,474
8,240
Selling General and Administrative
20,434
18,955
7,769
4,288
1,078
Total Operating Expenses
93,098
83,529
38,791
24,762
9,318
Operating Income or Loss
-93,098
-83,529
-38,791
-24,762
-9,318
Total Other Income/Expenses Net
-
-22
-
-
-9,679
Income Before Tax
-79,598
-71,584
-37,662
-24,740
-18,966
Income from Continuing Operations
-79,598
-71,584
-37,662
-24,740
-18,966
Net Income
-79,598
-71,584
-37,662
-24,740
-18,966
Net Income available to common shareholders
-79,598
-71,584
-37,662
-24,740
-18,966
Basic EPS
-0.92
-2.01
-0.92
-0.60
-0.46
Diluted EPS
-0.92
-2.01
-0.92
-0.60
-0.46
Basic Average Shares
41,100
35,546
41,100
41,100
41,100
Diluted Average Shares
41,100
35,546
41,100
41,100
41,100